Would pan-tuberculosis treatment regimens be cost-effective?

Article de revue

Avec comité de lecture

Emily A. Kendall, Grania Brigden, Christian Lienhardt et David W. Dowdy

The lancet respiratory medicine, Vol.6(7), pp.486-488

01/07/2018

PMID: 29859919

Résumé

Critical Care Medicine

General & Internal Medicine

Life Sciences & Biomedicine

Respiratory System

Science & Technology

1 Consultations de la notice

Titre: Would pan-tuberculosis treatment regimens be cost-effective?
Créateurs - sans rôle: Emily A. Kendall - Johns Hopkins Univ, Sch Med, Div Infect Dis, Ctr TB Res, 1550 Orleans St, Baltimore, MD 21230 USA
Grania Brigden - Int Union TB & Lung Dis, Geneva, Switzerland
Christian Lienhardt - WHO, Global TB Programme, Geneva, Switzerland
David W. Dowdy - Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
Détails de publication: The lancet respiratory medicine, Vol.6(7), pp.486-488
Éditeur: Elsevier
Nombre de pages: 4
Note de subvention: K08AI127908 / National Institution of Allergy and Infectious Diseases of the National Institutes of Health K08AI127908 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Identifiants: 99158547909311
Unité académique: Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Langue: English
Type de ressource: Journal article